Australia Is Battling Its Largest Diphtheria Outbreak in Living Memory
Australia is experiencing its largest diphtheria outbreak since the 1930s, with 230 confirmed cases and one adult death reported in 2026. The surge is concentrated in remote Indigenous communities across the Northern Territory and Western Australia, following an imported case in Queensland in 2022. Health officials cite vaccine misinformation, chronic nurse and doctor shortages, and overcrowded housing as primary catalysts. The outbreak underscores gaps in public‑health outreach and immunisation coverage in vulnerable populations.
Ebola Outbreak Prompts Scrutiny of Trump Cuts
The Trump administration’s deep cuts to USAID’s global health budget and its withdrawal from the World Health Organization are being blamed for a delayed response to the Ebola outbreak in the Democratic Republic of Congo and Uganda. Funding for U.S....
At Bio-IT World's 25th Anniversary, Rare Disease Takes Center Stage
At the 25th Bio‑IT World Conference, rare disease took center stage as leaders examined the puzzle from patient, AI‑diagnostic, investment, and policy angles. Patients like Tom Bartlett highlighted the chronic data gap between wearables and clinicians, while AI platforms such...
Return to Sport After Arthroscopic Rotator Cuff Repair: Epidemiology and Prognostic Factors in a Swiss Multi-Centre Cohort
A Swiss multi‑centre cohort of 725 patients undergoing arthroscopic rotator cuff repair (ARCR) tracked return‑to‑sport (RTS) outcomes over two years. By 12 months, 49.5% reported full RTS, rising to 57.4% at 24 months. Multivariable analysis identified younger age, traumatic tear,...
Coroner’s Court, Watchdog to Probe Delayed Blood Transfusion to Girl with Cancer
Hong Kong’s Medical Council and Coroner’s Court will hold a joint inquiry into the death of eight‑year‑old Chau Tin‑yu, who suffered a 48‑minute delayed blood transfusion during a 2020 surgery. The inquiry, set for Oct 27‑30, follows a police malpractice complaint...
Vitrafy Life Sciences Reports Strong US Army Platelet Preservation Results
Vitrafy Life Sciences announced that its Phase II in‑vitro study with the U.S. Army Institute of Surgical Research validated a no‑wash 3 % DMSO cryopreservation protocol, delivering a 94% mean post‑thaw platelet recovery. The protocol also outperformed wash‑based and trehalose approaches on...
Digital Suppression of Women’s Health Info Is Affecting Real-World Outcomes – and Government Needs to Act
Big tech platforms are increasingly shadow‑banning legitimate women’s health content, often flagging anatomical terms as adult material. A study commissioned by Essity shows 74% of 18‑34‑year‑olds turn to social media for health advice, yet women’s health posts suffer up to...
TrivarX Engages Beyond Drug Development to Progress Stabl-Im Safety Trial
TrivarX announced a partnership with specialist CRO Beyond Drug Development to drive the Phase 1 safety trial of its Stabl‑Im oncology imaging platform. Beyond will handle protocol finalisation, regulatory documentation and site selection as TrivarX prepares to dose healthy volunteers in...
The BioPharm Brief: Weight Loss, Oncology, Longevity
Merck has moved its antibody‑drug conjugate (ADC) targeting metastatic colorectal cancer into a Phase 3 trial, underscoring the growing confidence in precision oncology. Eli Lilly reported that its multi‑receptor obesity drug retatrutide achieved up to 28.3% weight loss in a pivotal Phase 3...
So-Young International Inc (SY) Q1 2026 Earnings Call Transcript
So-Young International posted record Q1 2026 revenue of RMB 451 million, a 25% year‑over‑year increase, driven by a 205% surge in aesthetic center revenue to RMB 248 million. The company now operates 49 medical aesthetic centers, with 10 new openings...
E&C Passes Wheelchair Access, ACO Digital Quality Bills
On May 21, 2026, the House Energy & Commerce Committee unanimously approved two bipartisan bills. One creates new Medicare billing codes specifically for wheelchairs, expanding coverage for patients who need mobility assistance. The second bill streamlines reporting requirements for providers...
Spinal Stimulation Data Reveal Why High-Frequency Pulses May Miss Key Nerve Pathways
A joint study by FAU, the Medical University of Vienna and Washington University combined human electrophysiology with high‑resolution digital‑twin simulations to show that high‑frequency, ultrashort pulses in non‑invasive spinal cord stimulation fail to activate key somatosensory pathways, limiting therapeutic benefit....
New Zealand Invests In Ambulance Workforce, Technology And Hubs To Meet Rising Emergency Demand
New Zealand’s 2026 budget earmarks NZ$35 million (about $21 million USD) over four years to expand ambulance crews, launch an electronic patient clinical record system, and build two new ambulance hubs in Auckland. The funding builds on earlier NZ$77.7 million (≈$46.6 million USD) contributions...
Senators Outline Plan For Medicare Home Care Benefit: What It Would Mean For Providers
A coalition of Democratic senators released a policy framework to add a dedicated home‑care benefit to Medicare and broaden Medicaid’s home‑ and community‑based services (HCBS). The proposal aims to make home care more affordable, improve quality in nursing homes, and...
Where RNs Are Most Concentrated: Rankings by State
The Bureau of Labor Statistics’ May 2025 data shows that while California and Texas employ the most registered nurses overall, their concentration per 1,000 jobs is relatively low. West Virginia tops the list with 33.4 RNs per 1,000 jobs, and Utah...
NIH Director Testifies on Staff Turnover, Funding Cuts Before Senate Committee: 3 Notes
NIH Director Jay Bhattacharya testified before a Senate appropriations subcommittee about staffing changes at NIAID and funding challenges. Senators highlighted that eight of the top ten NIAID officials have been reassigned, creating a leadership vacuum amid an Ebola outbreak. An...
20 Trends in Hospital Revenue
Hospitals reported solid revenue gains in Q1 2026, with net operating revenue up 5% and gross operating revenue up 7% year‑over‑year. Outpatient services drove the strongest growth, expanding 8% nationally and outpacing inpatient revenue, which rose only 4%. Regional and...
‘Rural Healthcare Is Under Attack’: California Hospital Turns to Strategic Partnerships to Combat Medicaid Cuts
Mad River Community Hospital in Arcata, California is confronting Medicaid reductions by forming an "insourcing" partnership with Ovation Healthcare to streamline revenue‑cycle operations. About 30 employees will transition to the new structure, while the hospital recently laid off eight to...
Justice Department Can Question Former Elevance Exec in Medicare Advantage Fraud Case, Judge Rules
A federal judge granted the Justice Department permission to depose former Elevance Health executive Peter Haytaian for 3.5 hours, rejecting the insurer’s attempt to limit the scope of questioning. The DOJ alleges Elevance, then Anthem, generated over $100 million annually by...
Outdated Technology Comes with a Human Cost
Outdated health‑IT systems are generating a growing technical debt that clogs clinician workflows and forces patients to repeat their medical histories. Joel Bond of Bond Consulting highlighted the issue at HIMSS26, noting that fragmented electronic health records and legacy network...
#ASCO26: Merck Partner Kelun Outlines Phase 3 Lung Cancer Success in China Study
Merck’s Chinese partner Kelun‑Biotech reported that its Phase 3 trial of the antibody‑drug conjugate sac‑TMT met its primary endpoints in patients with advanced non‑small cell lung cancer. The study, conducted across multiple sites in China, showed a statistically significant improvement in...
#ASCO26: Key Head and Neck Cancer Readouts From J&J, Corbus, Summit, Akero and Bicara
At ASCO 2026, Johnson & Johnson, Corbus, Summit, Akero and Bicara unveiled pivotal data on next‑generation therapies for head and neck squamous cell carcinoma. J&J’s pembrolizumab‑plus‑chemotherapy regimen reduced the risk of death by roughly 20% in first‑line patients. Corbus reported...
#ASCO26: New Data Released for VEGF Bispecifics From BioNTech-BMS, Pfizer-3SBio
At ASCO 2026, BioNTech‑BMS and Pfizer‑3SBio unveiled new Phase 1/2 data on their VEGF‑targeting bispecific antibodies. BioNTech‑BMS reported a 45% overall response rate in heavily pre‑treated solid‑tumor patients, while Pfizer‑3SBio’s candidate achieved disease control in 78% of a similar cohort....
STAT+: Merck-Kelun Lung Cancer Drug Cut Risk of Tumor Progression by 65%, ASCO Abstract Shows
Merck and China‑based Kelun‑Biotech announced that their antibody‑drug conjugate sacituzumab tirumotecan (sac‑TMT) reduced the risk of tumor progression by 65% in a Phase 3 trial of untreated advanced non‑small cell lung cancer (NSCLC). The study, conducted in China, also showed an...
Hospices Build Digitally Innovative Referral Streams
Hospice providers are turning to a blend of AI‑driven predictive analytics, digital storytelling, and hybrid virtual‑in‑person outreach to accelerate referrals and improve end‑of‑life care. Early identification of patients through machine‑learning models helps avoid late referrals that lead to short hospice...
News 5/22/26
The U.S. Food and Drug Administration granted clearance to a sepsis warning system co‑developed by Bayesian Health and Johns Hopkins University. The tool uses a Bayesian AI model to flag patients at risk of sepsis earlier than traditional methods. Early...
CVS Health Sued Over Alleged Scheme to Siphon 340B Drug Program Savings
Three major hospital systems sued CVS Health and its affiliates, alleging the company diverted roughly $250 million in savings from the federal 340B Drug Pricing Program between 2020 and 2025. The lawsuits claim CVS Specialty and its PBM unit paid hospitals...
Democrats Scrutinize CMS’ Unintentional Leak Of Provider Social Security Numbers
Top congressional Democrats are pressing the Centers for Medicare & Medicaid Services (CMS) for answers after the agency unintentionally released a batch of National Provider Directory records that included providers' Social Security numbers. The data breach was discovered when the...
FDA Warns Public About Johnson & Johnson Heart Pump Controllers After Patient Death
The FDA issued an early‑alert warning that Johnson & Johnson MedTech’s Automated Impella Controllers (AICs) can unexpectedly restart after at least 80 minutes without residual pulsatility, causing a 35‑second pump pause. The software glitch has been linked to two serious...
Eli Lilly’s Triple Combo Obesity Drug Tops 28% Weight Loss in a Pivotal Trial
Eli Lilly’s experimental obesity drug retatrutide delivered an average 28.3% weight loss – roughly 70 pounds – in its Phase 3 trial, with the highest dose leading the result. The study enrolled 2,339 participants without diabetes and tested three escalating doses, each outperforming...
Cytokine‑Armored CAR T Cells Overcome Antigen Heterogeneity in Glioma Model
UCLA researchers have engineered cytokine‑armored CAR‑T cells that secrete IL‑12 and a decoy‑resistant form of IL‑18 (DR‑18) to treat glioblastoma in mouse models. The IL‑12/DR‑18 combination enabled CAR‑T cells to eradicate tumors even when cancer cells lacked the targeted IL‑13Rα2...
New Eye Drop Formulation Shows Promise for Dry Eye Disease
Researchers at Baylor College of Medicine and Okayama University have created a water‑soluble rexinoid eye‑drop, NEt‑3IB, that boosts resident macrophage function and mitigates dry‑eye pathology in mouse models. The formulation significantly lowered ocular inflammation, preserved corneal barrier integrity and goblet...
Vitamin B12 Analog Targets Deadly Brain Cancer Cells
Researchers at Nitric Oxide Services and Cleveland Clinic have demonstrated that nitrosylcobalamin, a nitric‑oxide‑releasing vitamin B12 analog, can penetrate the blood‑brain barrier and preferentially accumulate in glioblastoma tissue in rat models. Pharmacokinetic data show sustained tumor nitrate levels for at...
Site-Centered Startup: Approaching Predictability in an Imperfect System
Study start‑up continues to be hampered by complex protocols, lengthy negotiations, and fragmented communication. ICON’s executive vice president Brian Mallon argues that a site‑centered model—integrating early feasibility with real‑world capacity, sustained momentum, and automation—can transform activation from an imperfect science...
Dermatologicals Top Workers Comp Drug Costs: Study
Dermatological agents topped workers‑compensation drug spending in early 2025, representing 23% of prescription payments on average and exceeding 30% in several states. More than 70% of these costs flowed through physician‑dispensing and delivery‑pharmacy channels, which dominated the market in 20...
Targeting Tumor-Specific Inflammatory Process May Prevent Drug Resistance in Colon Cancer
A preclinical study from Weill Cornell Medicine and MD Anderson reveals that colorectal tumors with KRAS mutations develop resistance to KRAS inhibitors primarily through a tumor‑specific inflammatory response rather than additional KRAS mutations. The researchers observed early up‑regulation of inflammatory...
Inside Denmark's New National Digital Healthcare Organisation
Denmark has created a new national digital health agency, led by deputy director Klaus Larsen of Digital Health Denmark, to centralize and accelerate digital transformation across the country’s healthcare system. The organization will standardize electronic health‑record platforms, expand telehealth services,...
Biovance 3L Offers Fast Healing, Efficient Surgery
Biovance 3L, a decellularized triple‑layered amniotic membrane from DefEYE, offers a purified scaffold that accelerates ocular wound healing. The product enables glueless, sutureless pterygium surgery, cutting procedure times to 7‑10 minutes versus the typical 14‑minute autograft approach. Dr. Neel Desai highlighted...
Advocacy Group Wants TAVR Changes, Urging Trump Admin to ‘Stop Getting in Between Patients and Their Doctors’
The Alliance for Aging Research is pressuring the Trump administration’s CMS to broaden Medicare coverage of transcatheter aortic valve replacement (TAVR). A poll of 1,000 U.S. adults showed 77% favor parity with open‑heart surgery coverage and 67% would back candidates...
Enhanced Ebola Airport Screening Begins at Washington-Dulles International Airport
On May 18, 2026 the CDC issued an order barring entry to the United States for foreign nationals who have been in the Democratic Republic of Congo, Uganda or South Sudan within the previous 21 days. A Federal Register notice...
Most Americans Misunderstand Which Sexually Transmitted Infections Have Preventive Vaccines
A new Annenberg Public Policy Center survey of 1,639 U.S. adults reveals major gaps in public knowledge about which sexually transmitted infections (STIs) are vaccine‑preventable. While 68% correctly identify an HPV vaccine and 42% know a mpox vaccine exists, most...
Inside the Quiet Reinvention of the Clinical Judgment Call
CARA Systems, a NYU spin‑out, introduced AneuView™, an AI‑driven, non‑invasive clinical decision‑support platform for neurovascular assessment. The tool consolidates imaging, patient history, and hemodynamic data into a patient‑specific risk profile, aiming to reduce reliance on invasive diagnostics and standardize triage....
Detroit EMS Crew Honored for Lifesaving Care After Shooting
During EMS Week 2026, Detroit’s emergency medical services crew received the Kim L. Lifesaver of the Year Award for their rapid care of a critically injured shooting victim on Feb. 18. The team stopped severe bleeding and treated a collapsed lung...
Foslevadopa/Foscarbidopa Saved Resources in Parkinson’s
A new subcutaneous formulation of foslevodopa/foscarbidopa (Vyalev) demonstrated substantial cost savings—over $110,000 per patient across five years—when compared with Best Medical Therapy for advanced Parkinson’s disease. Although the drug’s acquisition price is higher, the reduction in professional and informal caregiving...
Vaccines: Our Act of Love for Every Child
The Department of Health launched World Immunization Week in San Juan, Philippines, marking the 50th anniversary of the national immunization program. Mayor Francis Zamora highlighted the city’s effort to deliver 250 routine and catch‑up vaccine doses, targeting infants, students, pregnant...
Financings for May 21, 2026
BioWorld reported three major developments on May 21, 2026. Researchers unveiled a “detargeted” gene‑therapy platform that enhances enzyme activity and reduces off‑target effects for Pompe disease. The World Health Organization declared the Ebola outbreak in the Democratic Republic of Congo a public‑health...
Prescription-to-Nonprescription (Rx-to-OTC) Switches
The FDA permits sponsors to convert prescription drugs to over‑the‑counter status through a formal Rx‑to‑OTC switch, either as a full or partial transition. A full switch replaces the prescription label entirely, while a partial switch retains prescription status for certain...
Drug Application Process for Nonprescription Drugs
The FDA offers two routes—New Drug Application (NDA) and Abbreviated New Drug Application (ANDA)—to bring nonprescription drugs to market. Sponsors must secure approval before sales, and they can file directly for OTC status or transition a prescription product. Critical to...
RA Capital Banks $75M for a Biotech SPAC
RA Capital Management launched Research Alliance III, a biotech-focused SPAC that raised $75 million by selling 7.5 million shares at $10 each and began trading on Nasdaq under the ticker RACC. The vehicle seeks to merge with a China‑based drug development and diagnostic...
Inside The Nebraska Hospital Built To Contain Once-in-a-Generation Disease Threats
Nebraska Medicine’s National Quarantine Unit, the only federally funded quarantine facility in the United States, is now housing patients from a hantavirus outbreak on a cruise ship. The center, part of the University of Nebraska Medical Center, has built a...